Resources Archive - Page 22 of 48

Paclitaxel-Resistant Tumor Models

Despite the excellent clinical response to paclitaxel therapy, drug resistance inevitably develops in subsequent treatments. The mechanisms for resistance to...

NK Cell Humanized Tumor Models

NK cells are effector innate lymphoid cells (ILCs) that do not require antigen-specific priming. NK cells are not only killer...

Poster Presentations at IMMUNOLOGY2024

Join WuXi AppTec at IMMUNOLOGY2024™. For this year’s annual meeting of the American Association of Immunologists (AAI), WuXi Biology has...

OncoWuXi Express: AAI 2024 Posters: Sneak Peek

OncoWuXi Express| Immunology 2024™ Poster Sneak Peek Introduction： OncoWuXi Express will continue to keep you informed about updates to our...

Discovery, Characterization, and Manufacture of Peptide Radiopharmaceuticals

A new wave of drugs that achieves targeted delivery of radioisotopes is rapidly gaining momentum. As the discovery pipeline widens...

Orthotopic and Metastasis Tumor Models in Rats

Rat tumor models are a better mimic of human pathology compared to mice. The tumor stroma component of rats is...

Syngeneic Tumor Models with Resistance Mechanisms to PD-1 Blockade

PD-1 blockade has demonstrated remarkable clinical efficacy across various tumor types. However, primary or acquired resistance eventually leads to cancer...